These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24899155)

  • 1. Serum lipid responses to weight loss differ between overweight adults with familial hypercholesterolemia and those with familial combined hyperlipidemia.
    Mateo-Gallego R; Perez-Calahorra S; Cofán M; Baila-Rueda L; Cenarro A; Ros E; Puzo J; Civeira F
    J Nutr; 2014 Aug; 144(8):1219-26. PubMed ID: 24899155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol oversynthesis markers define familial combined hyperlipidemia versus other genetic hypercholesterolemias independently of body weight.
    Baila-Rueda L; Cenarro A; Lamiquiz-Moneo I; Perez-Calahorra S; Bea AM; Marco-Benedí V; Jarauta E; Mateo-Gallego R; Civeira F
    J Nutr Biochem; 2018 Mar; 53():48-57. PubMed ID: 29190549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions.
    Ellis KL; Pang J; Chan DC; Hooper AJ; Bell DA; Burnett JR; Watts GF
    J Clin Lipidol; 2016; 10(6):1329-1337.e3. PubMed ID: 27919349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial Hypercholesterolemia, Familial Combined Hyperlipidemia, and Elevated Lipoprotein(a) in Patients With Premature Coronary Artery Disease.
    Vikulova DN; Trinder M; Mancini GBJ; Pimstone SN; Brunham LR
    Can J Cardiol; 2021 Nov; 37(11):1733-1742. PubMed ID: 34455025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma proprotein convertase subtilisin kexin type 9 levels are related to markers of cholesterol synthesis in familial combined hyperlipidemia.
    Brouwers MC; Konrad RJ; van Himbergen TM; Isaacs A; Otokozawa S; Troutt JS; Schaefer EJ; van Greevenbroek MM; Stalenhoef AF; de Graaf J
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1115-21. PubMed ID: 23333725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension.
    Hunt SC; Wu LL; Hopkins PN; Stults BM; Kuida H; Ramirez ME; Lalouel JM; Williams RR
    Arteriosclerosis; 1989; 9(3):335-44. PubMed ID: 2497719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutrition, body weight and deterioration of familial combined hyperlipidemia.
    Koprovicová J; Kollár J; Petrásová D
    Coll Antropol; 2006 Dec; 30(4):777-82. PubMed ID: 17243549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile acid synthesis precursors in familial combined hyperlipidemia: the oxysterols 24S-hydroxycholesterol and 27-hydroxycholesterol.
    Baila-Rueda L; Mateo-Gallego R; Jarauta E; de Castro-Orós I; Bea AM; Cenarro A; Civeira F
    Biochem Biophys Res Commun; 2014 Apr; 446(3):731-5. PubMed ID: 24406166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition of familial dyslipidemias in 5-year-old children using the lipid phenotypes of parents. The STRIP project.
    Lapinleimu J; Nuotio IO; Lapinleimu H; Simell OG; Rask-Nissila L; Viikari JS
    Atherosclerosis; 2002 Feb; 160(2):417-23. PubMed ID: 11849666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of age and relative weight on the presentation of familial combined hyperlipidemia in childhood.
    Shamir R; Tershakovec AM; Gallagher PR; Liacouras CA; Hayman LL; Cortner JA
    Atherosclerosis; 1996 Mar; 121(1):85-91. PubMed ID: 8678927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein B is associated with metabolic syndrome in Chinese families with familial combined hyperlipidemia, familial hypertriglyceridemia and familial hypercholesterolemia.
    Pei WD; Sun YH; Lu B; Liu Q; Zhang CY; Zhang J; Jia YH; Lu ZL; Hui RT; Liu LS; Yang YJ
    Int J Cardiol; 2007 Mar; 116(2):194-200. PubMed ID: 16828905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma non-cholesterol sterols: a useful diagnostic tool in pediatric hypercholesterolemia.
    Noto D; Cefalù AB; Barraco G; Martino E; Fayer F; Minà M; Montali A; Arca M; Averna M; Martino F
    Pediatr Res; 2010 Feb; 67(2):200-4. PubMed ID: 20091938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in ultracentrifugally separated plasma lipoprotein subfractions in patients with polygenic hypercholesterolemia, familial combined hyperlipoproteinemia, and familial hypercholesterolemia after treatment with atorvastatin.
    Homma K; Homma Y; Yoshida T; Ozawa H; Shiina Y; Wakino S; Hayashi K; Itoh H; Hori S
    J Clin Lipidol; 2015; 9(2):210-6. PubMed ID: 25911077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor alpha (TNFalpha) and its soluble receptor p75 (sTNF-R p75) in familial combined hyperlipidemia (FCHL).
    Cavallo MG; Montali A; Monetini L; Valente L; Mariani P; Bifolco M; Sirinian MI; Antonini TM; Fioretti F; Campagna F; Verna R; Arca M
    Nutr Metab Cardiovasc Dis; 2005 Aug; 15(4):262-9. PubMed ID: 16054550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of cholestyramine in the treatment of children with familial combined hyperlipidemia.
    Liacouras CA; Coates PM; Gallagher PR; Cortner JA
    J Pediatr; 1993 Mar; 122(3):477-82. PubMed ID: 8441109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squalene and noncholesterol sterols in serum and lipoproteins of children with and without familial hypercholesterolemia.
    Ketomäki A; Gylling H; Siimes MA; Vuorio A; Miettinen TA
    Pediatr Res; 2003 Apr; 53(4):648-53. PubMed ID: 12612218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased arterial stiffness in familial combined hyperlipidemia.
    Brouwers MC; Reesink KD; van Greevenbroek MM; Meinders JM; van der Kallen CJ; Schaper N; Hoeks AP; Stehouwer CD
    J Hypertens; 2009 May; 27(5):1009-16. PubMed ID: 19402225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year follow-up of waist circumference, insulin and ALT levels in familial combined hyperlipidaemia.
    Brouwers MC; van Greevenbroek MM; Vermeulen VM; van Lin JM; van der Kallen CJ; de Bruin TW
    Clin Sci (Lond); 2007 Nov; 113(9):375-81. PubMed ID: 17564583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary Fat Intake Modifies the Effect of a Common Variant in the LIPC Gene on Changes in Serum Lipid Concentrations during a Long-Term Weight-Loss Intervention Trial.
    Xu M; Ng SS; Bray GA; Ryan DH; Sacks FM; Ning G; Qi L
    J Nutr; 2015 Jun; 145(6):1289-94. PubMed ID: 25926410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased intima-media thickness in familial combined hyperlipidemia associated with apolipoprotein B.
    Keulen ET; Kruijshoop M; Schaper NC; Hoeks AP; de Bruin TW
    Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):283-8. PubMed ID: 11834529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.